KEYNOTE-799：帕博利珠单抗联合同步放化疗治疗Ⅲ期不可切除NSCLC的Ⅱ期临床研究
评价者：熊乐1, 刘安文1, 文献合成者：陈志勇2

KEYNOTE-799： Pembrolizumab Plus Concurrent Chemoradiation in Unresectable, Locally Advanced, Stage Ⅲ Non-Small Cell Lung Cancer
Reviewers： XIONG Le1, LIU An-wen1, Literature Co-worker： CHEN Zhi-yong2